{"nct_id":"NCT05822752","title":"Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2023-09-21","start_date_type":"ACTUAL","primary_completion_date":"2026-11","primary_completion_date_type":"ESTIMATED","completion_date":"2026-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}